Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bonnard

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Antiviral Therapy|October 12, 2012
Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohortMarc-Arthur Loko, Firouze Bani-Sadr, Marc-Antoine Valantin, et al.
Cytokine|May 14, 2013
CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patientsDina Ragab, Melissa Laird, Darragh Duffy, et al.
Journal of Hepatology|June 7, 2014
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infectionMelissa E Laird, Amira Mohsen, Darragh Duffy, et al.
Journal of Hepatology|August 15, 2018
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in AfricaYusuke Shimakawa, Ramou Njie, Gibril Ndow, et al.
BMC Infectious Diseases|October 26, 2010
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010Marc-Arthur Loko, Dominique Salmon, Patrizia Carrieri, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Antiviral Therapy|October 12, 2012
Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohortMarc-Arthur Loko, Firouze Bani-Sadr, Marc-Antoine Valantin, et al.
Cytokine|May 14, 2013
CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patientsDina Ragab, Melissa Laird, Darragh Duffy, et al.
Journal of Hepatology|June 7, 2014
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infectionMelissa E Laird, Amira Mohsen, Darragh Duffy, et al.
Journal of Hepatology|August 15, 2018
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in AfricaYusuke Shimakawa, Ramou Njie, Gibril Ndow, et al.
BMC Infectious Diseases|October 26, 2010
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010Marc-Arthur Loko, Dominique Salmon, Patrizia Carrieri, et al.
Pageof 4